« Return to News | Awards & Advancement

University of Maryland receives $23 million for HIV vaccine

Friday, May 6, 2011 12:23 PM

Scientists at the University of Maryland School of Medicine will be able to move forward on decades-long work for a promising HIV/AIDS vaccine after receiving $23.4 million from a consortium led by The Bill & Melinda Gates Foundation, according to The Baltimore Sun.

The money was awarded to the university's Institute of Human Virology, headed by Dr. Robert Gallo, who helped discover the human immunodeficiency virus.   

The vaccine being researched would potentially neutralize different strains of HIV. The researchers say previous vaccine candidates responded only to single strains or narrow ranges of the disease.

The Bill & Melinda Gates Foundation donated $16.8 million to the research, while the Army's Military HIV Research Program provided $2.2 million. The National Institutes of Health and others also have contributed funds.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.